Clopidogrel or apixaban in atrial fibrillation patients unsuitable for vitamin-K antagonists for stroke prevention in atrial fibrillation? Lessons from the recent aspirin-controlled trials

被引：0
|
作者：
Verheugt, F. W. A. [1 ]
Jaspersfocks, J. [2 ]
Brouwer, M. A. [2 ]
机构：
[1] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, NL-6525 ED Nijmegen, Netherlands
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [1] Clopidogrel or apixaban in atrial fibrillation patients unsuitable for vitamin-K antagonists for stroke prevention in atrial fibrillation? Lessons from the recent aspirin-controlled trials
    Verheugt, F. W. A.
    Jaspersfocks, J.
    Brouwer, M. A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 672 - 672
  • [2] DUAL ANTIPLATELET THERAPY OR APIXABAN IN PATIENTS INELIGIBLE FOR VITAMIN-K ANTAGONISTS FOR STROKE PREVENTION IN ATRIAL FIBRILLATION: LESSONS FROM THE RECENT ASPIRIN-CONTROLLED TRIALS
    Focks, Jeroen Jaspers
    Brouwer, Marc A.
    Verheugt, Freek W. A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E61 - E61
  • [3] Net Clinical Benefit of Adding Clopidogrel to Aspirin Therapy in Patients With Atrial Fibrillation for Whom Vitamin K Antagonists Are Unsuitable
    Connolly, Stuart J.
    Eikelboom, John W.
    Ng, Jennifer
    Hirsh, Jack
    Yusuf, Salim
    Pogue, Janice
    de Caterina, Raffaele
    Hohnloser, Stefan
    Hart, Robert G.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (09) : 579 - U41
  • [4] Apixaban triumphs over aspirin for stroke prevention in patients with atrial fibrillation
    Alexandra King
    Nature Reviews Cardiology, 2011, 8 (4) : 181 - 181
  • [5] Lessons from the Stroke Prevention in Atrial Fibrillation trials
    Hart, RG
    Halperin, JL
    Pearce, LA
    Anderson, DC
    Kronmal, RA
    McBride, R
    Nasco, E
    Sherman, DG
    Talbert, RL
    Marler, JR
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) : 831 - 838
  • [6] Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
    Lee, Soyon
    Anglade, Moise W.
    Meng, Joy
    Hagstrom, Kelly
    Kluger, Jeffrey
    Coleman, Craig I.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2012, 5 (04): : 472 - 479
  • [7] Cost-Effectiveness of Clopidogrel Plus Aspirin for Stroke Prevention in Patients With Atrial Fibrillation in Whom Warfarin Is Unsuitable
    Coleman, Craig I.
    Straznitskas, Andrew D.
    Sobieraj, Diana M.
    Kluger, Jeffrey
    Anglade, Moise W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 109 (07): : 1020 - 1025
  • [8] Clopidogrel Plus Aspirin is Cost-Effective for Stroke Prevention in Patients with Atrial Fibrillation in Whom Warfarin is Unsuitable
    Coleman, Craig I.
    Straznitskas, Andrew D.
    Sobieraj, Diana M.
    Kluger, Jeffrey
    CIRCULATION, 2011, 124 (21)
  • [9] Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial
    Flaker, Greg C.
    Eikelboom, John W.
    Shestakovska, Olga
    Connolly, Stuart J.
    Kaatz, Scott
    Budaj, Andrzej
    Husted, Steen
    Yusuf, Salim
    Lip, Gregory Y. H.
    Hart, Robert G.
    STROKE, 2012, 43 (12) : 3291 - +
  • [10] Apixaban for Prevention of Stroke in Patients with subclinical Atrial Fibrillation
    Dovjak, Peter
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2024, 57 (05): : 412 - 412
12345